Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 19, 2023 - Issue 2
Submit an article Journal homepage
1,780
Views
6
CrossRef citations to date
0
Altmetric
Pneumococcal

Cost-effectiveness analysis of PCV20 to prevent pneumococcal disease in the Canadian pediatric population

Derek Lytlea Market Access, Pfizer Canada, Kirkland, QC, CanadaCorrespondence[email protected]
View further author information
,
Ana Gabriela Grajales Beltránb Vaccines Medical Affairs, Pfizer Canada, Kirkland, QC, CanadaView further author information
,
Johnna Perdrizetc Global Value and Evidence, Pfizer Canada, Kirkland, QC, CanadaView further author information
,
Nassim Ait Yahiaa Market Access, Pfizer Canada, Kirkland, QC, CanadaView further author information
,
Alejandro Caned Vaccines Medical and Scientific Affairs, North America, Pfizer Inc, Collegeville, PA, USAView further author information
,
Benjamin Yarnoffe Modeling & Simulation,Evidera, Bethesda, MD, USAView further author information
&
Ruth Chapmanf Modeling & Simulation,Evidera, London, UKView further author information
 show all
Article: 2257426 | Received 15 Jun 2023, Accepted 07 Sep 2023, Published online: 29 Sep 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.